Ligand ID: MRC


Drugbank ID:
DB00410
(Mupirocin)


Indication:
For the treatment of Staphylococci nasal carriers.

Get human targets for MRC in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'MRC'

Click here for results that match SARS-Cov-2 / COVID-19 structures only
Click here for results that match SARS-related structures only


1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		1q2w 3C-LIKE PROTEASE
(SARSr-CoV)		5 / 11
GLY B 124
PRO A   9
SER A  10
GLY B 149
LEU B 177
1.71A17.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2a5k 3C-LIKE PEPTIDASE
(SARSr-CoV)		5 / 11
GLY B 124
PRO A   9
SER A  10
GLY B 149
LEU B 177
1.68A17.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_2
(ISOLEUCYL-TRNA
SYNTHETASE)		2ajf ACE2
(Homo
sapiens)		4 / 6
PRO A 538
HIS A 535
GLU A 430
LYS A 553
1.70A21.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2d2d 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
GLY A 124
PRO B   9
SER B  10
GLY A 149
LEU A 177
1.67A17.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2gdt NSP1 (EC 3.4.22.-)
P65 HOMOLOG
LEADER PROTEIN
(SARSr)		5 / 12
HIS A  70
GLY A  71
HIS A  70
ASN A  69
LYS A   1
1.27A11.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2gdt NSP1 (EC 3.4.22.-)
P65 HOMOLOG
LEADER PROTEIN
(SARSr)		5 / 12
GLY A  71
HIS A  70
GLY A  71
HIS A  72
VAL A  74
1.21A11.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2gdt NSP1 (EC 3.4.22.-)
P65 HOMOLOG
LEADER PROTEIN
(SARSr)		5 / 12
HIS A  70
GLY A  71
HIS A  70
ASN A  69
VAL A  74
1.20A11.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2gdt LEADER PROTEIN
P65 HOMOLOG
NSP1
(SARSr-CoV)		5 / 12
GLY A  71
HIS A  70
ASN A  69
VAL A  74
LYS A   1
1.70A11.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2op9 REPLICASE
POLYPROTEIN 1AB
(PP1AB, ORF1AB)
3C-LIKE PROTEINASE
(3CL-PRO, 3CLP)
(SARSr-CoV)		5 / 12
PRO A 168
GLY A 138
GLY A 174
HIS A 163
VAL A 114
1.67A15.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2op9 REPLICASE
POLYPROTEIN 1AB
(PP1AB, ORF1AB)
3C-LIKE PROTEINASE
(3CL-PRO, 3CLP)
(SARSr-CoV)		5 / 12
PRO A 168
GLY A 138
GLY A 174
HIS A 163
VAL A 114
1.67A15.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2op9 REPLICASE
POLYPROTEIN 1AB
(PP1AB, ORF1AB)
3C-LIKE PROTEINASE
(3CL-PRO, 3CLP)
(SARSr-CoV)		5 / 11
GLY B 124
PRO A   9
SER A  10
GLY B 149
LEU B 177
1.71A17.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2ozk URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 12
HIS B 249
GLY B 238
SER D 328
GLN B 244
VAL B 236
1.74A18.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2ozk URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 12
HIS B 249
GLY B 238
SER D 328
GLN B 244
VAL B 236
1.74A18.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2pwx 3C-LIKE PROTEINASE
(SARS-COV
BJ01)		5 / 12
ASN A 142
SER A 284
GLY A 138
HIS A 172
PHE A 140
1.59A16.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2q6g REPLICASE
POLYPROTEIN 1AB
(SARS-COV
BJ01)		5 / 11
GLY A 124
PRO B   9
SER B  10
GLY A 149
LEU A 177
1.70A18.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2qcy 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ASN A 142
SER A 284
GLY A 138
HIS A 172
PHE A 140
1.74A16.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_2
(ISOLEUCYL-TRNA
SYNTHETASE)		2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		3 / 3
GLU F 266
TRP D  58
LYS D 204
1.77A19.39
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2vj1 MAIN PROTEINASE
(SARSr-CoV)		5 / 11
GLY B 124
PRO A   9
SER A  10
GLY B 149
LEU B 177
1.70A17.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2xyq PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		5 / 12
HIS A  69
GLY A  81
ASN A  43
SER A 175
ASP A  99
1.52A14.97
None
SAH  A1293 (-3.6A)
SAH  A1293 (-3.8A)
None
SAH  A1293 (-2.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		2xyr PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		5 / 12
HIS A  69
GLY A  81
ASN A  43
SER A 175
ASP A  99
1.54A14.98
None
SFG  A1298 (-3.5A)
SFG  A1298 (-3.5A)
None
SFG  A1298 (-2.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3aw1 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
GLY B 120
ASN B 119
SER A 301
GLY B 143
VAL B  18
1.68A16.48
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3ea7 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
GLY A 124
PRO B   9
SER B  10
GLY A 149
LEU A 177
1.70A17.64
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3f9e 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ASN A 142
SER A 284
GLY A 138
HIS A 172
PHE A 140
1.58A16.04
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3f9f 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
GLY B 124
PRO A   9
SER A  10
GLY B 149
LEU B 177
1.71A18.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3i6g HLA, A-2
MEMBRANE PROTEIN
(Homo
sapiens)		5 / 12
GLN D  72
HIS D  74
PHE F   7
VAL F   8
LYS D 146
1.78A15.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3i6k HLA, A-2
(Homo
sapiens)		5 / 11
PRO E 267
HIS A   3
ASP A 106
GLN E 262
LEU A 110
1.62A16.24
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3iwm 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
GLY B 124
PRO A   9
SER A  10
GLY B 149
LEU B 177
1.68A17.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3iwm 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
PRO A 168
GLY A 138
GLY A 174
HIS A 163
VAL A 114
1.53A16.37
02J  H   1 (-3.8A)
None
None
PJE  H   5 (-4.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3iwm 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
PRO A 168
GLY A 138
GLY A 174
HIS A 163
VAL A 114
1.53A16.37
02J  H   1 (-3.8A)
None
None
PJE  H   5 (-4.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3m3s 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
GLY A 124
PRO B   9
SER B  10
GLY A 149
LEU A 177
1.70A17.76
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3m3t 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ASN A 142
SER A 284
GLY A 138
HIS A 172
PHE A 140
1.67A16.48
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3m3v 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
GLY B 124
PRO A   9
SER A  10
GLY B 149
LEU B 177
1.71A17.75
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3r24 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		5 / 12
HIS A  69
GLY A  81
ASN A  43
SER A 175
ASP A  99
1.60A15.98
None
SAM  A 302 (-3.4A)
SAM  A 302 (-3.5A)
None
SAM  A 302 (-2.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3r24 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		5 / 12
HIS A  69
GLY A  81
ASN A  43
SER A 175
ASP A  99
1.57A15.98
None
SAM  A 302 (-3.4A)
SAM  A 302 (-3.5A)
None
SAM  A 302 (-2.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3r24 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		5 / 11
HIS A 119
SER A 129
GLY A 113
ASP A 114
ILE A 294
1.19A16.18
None
None
None
SAM  A 302 (-3.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_2
(ISOLEUCYL-TRNA
SYNTHETASE)		3sci ACE2
(Homo
sapiens)		4 / 6
PRO A 538
HIS A 535
GLU A 430
LYS A 553
1.66A21.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3scl ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
SER B  44
ASP B 382
HIS B 378
VAL B 404
MET B 557
1.77A21.40
None
None
ZN  B 901 (-4.1A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		3scl ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
SER B  44
ASP B 382
HIS B 378
VAL B 404
MET B 557
1.77A21.40
None
None
ZN  B 901 (-4.1A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_2
(ISOLEUCYL-TRNA
SYNTHETASE)		3scl ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		4 / 6
PRO A 538
HIS A 535
GLU A 430
LYS A 553
1.60A21.40
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		4hi3 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
GLY A 124
PRO B   9
SER B  10
GLY A 149
LEU A 177
1.70A17.95
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		4ovz PAPAIN-LIKE
PROTEINASE
(SARS-COV
Urbani)		5 / 11
HIS B 172
SER A 246
GLY B 164
LEU B 153
ILE B 152
1.58A17.60
None
None
P85  B 902 ( 3.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		4tww 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
GLY B 124
PRO A   9
SER A  10
GLY B 149
LEU B 177
1.62A17.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5b6o 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
GLY A 124
PRO B   9
SER B  10
GLY A 149
LEU A 177
1.71A17.31
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5c8s GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
HIS B 427
GLY B 413
GLN B 262
HIS B 264
VAL B 282
1.57A21.82
None
None
None
ZN  B 602 (-2.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5c8s GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
HIS B 427
GLY B 413
GLN B 262
HIS B 264
VAL B 282
1.57A21.82
None
None
None
ZN  B 602 (-2.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5c8s GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
HIS B 427
GLY B 413
GLN B 262
HIS B 264
VAL B 282
1.56A21.82
None
None
None
ZN  B 602 (-2.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5c8u GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
HIS B 427
GLY B 413
GLN B 262
HIS B 264
VAL B 282
1.43A21.17
None
None
None
ZN  B 602 (-2.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5c8u GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
HIS B 427
GLY B 413
GLN B 262
HIS B 264
VAL B 282
1.43A21.17
None
None
None
ZN  B 602 (-2.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5c8u GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
HIS B 427
GLY B 413
GLN B 262
HIS B 264
VAL B 282
1.43A21.17
None
None
None
ZN  B 602 (-2.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 12
HIS D 427
GLY D 413
ASP D 415
HIS D 264
VAL D 282
1.55A21.39
None
None
None
ZN  D 602 (-3.2A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 11
GLY B  93
PRO B 106
HIS N  -1
HIS B  95
SER B 194
1.71A19.76
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 12
HIS D 427
GLY D 413
ASP D 415
HIS D 264
VAL D 282
1.55A21.39
None
None
None
ZN  D 602 (-3.2A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 12
HIS D 427
GLY D 413
ASP D 415
HIS D 264
VAL D 282
1.58A21.39
None
None
None
ZN  D 602 (-3.2A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5r84 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
PRO A 168
GLY A 138
GLY A 174
HIS A 163
VAL A 114
1.70A15.38
None
None
None
GWS  A1001 (-3.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5r84 3C-LIKE PROTEINASE
(SARS-CoV-2)		5 / 12
PRO A 168
GLY A 138
GLY A 174
HIS A 163
VAL A 114
1.70A15.38
None
None
None
GWS  A1001 (-3.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5wrg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PRO B 844
ASP B 849
HIS B1040
PHE B 805
VAL B 808
1.59A22.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5wrg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 11
HIS A1040
ASP A 757
GLN A 756
LEU A 847
ILE A 852
1.58A21.18
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5wrg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PRO B 844
ASP B 849
HIS B1040
PHE B 805
VAL B 808
1.59A22.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5x4r S PROTEIN
(MERS-CoV)		5 / 11
HIS A 264
SER A 151
GLY A 115
LEU A  74
ILE A  57
1.41A17.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5x4s SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
GLY A  86
ASN A 189
SER A 111
PHE A 187
VAL A 186
1.53A13.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5x58 SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 12
GLY C  86
ASN C 189
SER C 111
PHE C 187
VAL C 186
1.46A21.44
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 12
GLY A  86
ASN A 189
SER A 111
PHE A 187
VAL A 186
1.43A21.44
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 12
PRO B 844
GLY B1041
HIS B1040
ASP B 849
VAL B1042
1.71A21.44
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5x5c S PROTEIN
(MERS-CoV)		5 / 12
PRO A  47
GLY A  55
ASP A 338
GLN A  78
PHE A 323
1.63A21.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5x5c S PROTEIN
(MERS-CoV)		5 / 12
PRO A 936
ASN A 839
GLN A 800
PHE A1081
VAL A1082
1.53A21.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5x5f S PROTEIN
(MERS-CoV)		5 / 11
HIS A 264
SER A 151
GLY A 115
LEU A  74
ILE A  57
1.41A20.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		5x5f S PROTEIN
(MERS-CoV)		5 / 12
GLY C 262
ASN B 521
ASP B 580
GLN B 576
VAL C 263
1.51A21.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_2
(ISOLEUCYL-TRNA
SYNTHETASE)		5x5f S PROTEIN
(MERS-CoV)		4 / 6
PRO A  45
HIS A  81
TRP A 253
LYS A 698
1.71A21.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PRO C 844
GLY C1041
HIS C1040
ASP C 849
VAL C1042
1.48A21.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
GLY B  86
ASN B 189
SER B 111
PHE B 187
VAL B 186
1.15A21.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
GLY B  86
ASN B 189
SER B 111
PHE B 187
VAL B 186
1.18A21.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 11
SER B 717
GLY C 634
GLN C 599
LEU C 636
ILE C 637
1.45A21.18
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
GLY A  68
ASN A  29
ASP A 208
HIS A  70
PHE A 253
1.62A21.92
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
PRO C 844
ASP C 849
HIS C1040
PHE C 805
VAL C 808
1.59A21.92
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
PRO C 844
ASP C 849
HIS C1040
PHE C 805
VAL C 808
1.59A21.92
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6crx SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
PRO A 844
ASP A 849
HIS A1040
PHE A 805
VAL A 808
1.55A21.90
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6cs1 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 11
GLY A 579
SER B 717
GLY A 634
GLN A 599
LEU A 636
1.57A21.36
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6cs2 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
GLY C  86
ASN C 189
SER C 111
PHE C 187
VAL C 186
1.56A21.90
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6cs2 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
PRO A 844
GLY A1041
HIS A1040
ASP A 849
VAL A1042
1.52A21.90
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6jyt HELICASE
(SARSr-CoV)		5 / 12
PRO B  77
GLY B  54
HIS B  75
SER B  80
VAL A  45
1.76A20.85
None
None
ZN  B 702 (-3.3A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6m0j ACE2
SPIKE RECEPTOR
BINDING DOMAIN
(Homo
sapiens;
SARS-CoV-2)		5 / 12
GLY E 446
ASN E 448
GLY E 496
ASP A  38
VAL E 445
1.52A13.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6m17 ACE2
RECEPTOR BINDING
DOMAIN
(Homo
sapiens;
SARS-CoV-2)		5 / 12
GLY F 447
ASN F 448
GLY F 496
ASP D  38
VAL F 445
1.76A13.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6m18 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		5 / 11
GLY C 284
SER C 122
GLY C  99
ASP C 445
ILE C  15
1.57A20.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6m1d SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		5 / 12
HIS C  65
ASN C 258
GLY C  67
GLN C  63
PHE C  70
1.77A20.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 11
GLY D 124
PRO B   9
SER B  10
GLY D 149
LEU D 177
1.71A17.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 11
GLY C 124
PRO A   9
SER A  10
GLY C 149
LEU C 177
1.71A17.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 11
PRO B 168
HIS B 163
HIS B 172
GLN B 189
LEU B  27
1.71A17.21
None
None
None
3WL  B 401 (-4.0A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6nb6 SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 11
GLY C 579
SER B 717
GLY C 634
LEU C 636
ILE C 637
1.58A20.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6nb6 SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PRO A 844
ASP A 849
HIS A1040
PHE A 805
VAL A 808
1.59A21.48
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6nb6 SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
PRO A 844
ASP A 849
HIS A1040
PHE A 805
VAL A 808
1.59A21.48
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6nb8 S230 ANTIGEN-BINDING
(FAB) FRAGMENT,
HEAVY CHAIN
S230 ANTIGEN-BINDING
(FAB) FRAGMENT,
LIGHT CHAIN
(Homo
sapiens)		5 / 12
SER L  26
GLY L  96
GLN L  95
HIS H 112
PHE H 111
1.40A12.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_2
(ISOLEUCYL-TRNA
SYNTHETASE)		6nb8 S230 ANTIGEN-BINDING
(FAB) FRAGMENT,
HEAVY CHAIN
S230 ANTIGEN-BINDING
(FAB) FRAGMENT,
LIGHT CHAIN
(Homo
sapiens)		3 / 3
GLU H   6
TRP H  36
LYS L 108
1.72A13.80
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6nb8 S230 ANTIGEN-BINDING
(FAB) FRAGMENT,
HEAVY CHAIN
S230 ANTIGEN-BINDING
(FAB) FRAGMENT,
LIGHT CHAIN
(Homo
sapiens)		5 / 12
SER L  26
GLY L  96
GLN L  95
HIS H 112
PHE H 111
1.40A12.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6nus NSP12
(SARSr-CoV)		5 / 12
GLY A 345
SER A 561
GLN A 661
PHE A 348
VAL A 353
1.77A22.31
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6nus NSP12
(SARSr-CoV)		5 / 12
GLY A 345
SER A 561
GLN A 661
PHE A 348
VAL A 353
1.77A22.31
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
PRO C 862
ASP C 867
HIS C1058
PHE C 823
VAL C 826
1.53A21.90
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 11
SER C 735
GLY B 648
GLN B 613
LEU B 650
ILE B 651
1.34A20.75
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
GLY A 857
ASN C 317
GLY C 594
ASP C 614
VAL A 736
1.44A21.90
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6vw1 SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
PRO E 499
GLY E 404
ASN E 437
SER E 445
VAL E 407
1.78A13.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
PRO A 862
GLY A1059
HIS A1058
ASP A 867
VAL A1060
1.62A21.52
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 11
GLY A 526
PRO A 527
SER A 366
GLY A 545
ILE A 326
1.55A21.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
PRO B 862
ASP B 867
HIS B1058
PHE B 823
VAL B 826
1.62A21.52
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
PRO B 862
ASP B 867
HIS B1058
PHE B 823
VAL B 826
1.62A21.52
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6vyo NUCLEOPROTEIN
(SARS-CoV-2)		5 / 11
GLY B 147
HIS A  59
HIS B 145
SER B  51
LEU A  56
1.28A11.00
None
ZN  B 201 ( 3.3A)
ZN  B 201 ( 3.3A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6w4h NSP16
(SARS-CoV-2)		5 / 12
HIS A6867
GLY A6879
ASN A6841
SER A6973
ASP A6897
1.50A16.14
None
SAM  A7102 (-3.4A)
SAM  A7102 (-3.6A)
ACT  A7104 ( 4.8A)
SAM  A7102 (-2.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
HIS A6867
GLY A6879
ASN A6841
SER A6973
ASP A6897
1.52A
None
SAM  A7104 (-3.6A)
SAM  A7104 (-3.3A)
EDO  A7102 ( 4.7A)
SAM  A7104 (-2.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
HIS A6867
GLY A6879
ASN A6841
SER A6973
ASP A6897
1.56A
None
SAM  A7104 (-3.6A)
SAM  A7104 (-3.3A)
EDO  A7102 ( 4.7A)
SAM  A7104 (-2.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
HIS A6867
ASN A6841
SER A6973
ASP A6897
PHE A6901
1.71A
None
SAM  A7104 (-3.3A)
EDO  A7102 ( 4.7A)
SAM  A7104 (-2.8A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
HIS A6867
GLY A6879
ASN A6841
GLY A6871
ASP A6897
1.62A
None
SAM  A7104 (-3.6A)
SAM  A7104 (-3.3A)
SAM  A7104 (-4.4A)
SAM  A7104 (-2.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
HIS A6867
GLY A6879
ASN A6841
SER A6973
ASP A6897
1.50A11.07
None
SAM  A7102 ( 3.4A)
SAM  A7102 ( 3.4A)
None
SAM  A7102 ( 2.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
HIS C6867
ASN C6841
SER C6973
ASP C6897
PHE C6901
1.63A11.07
None
SAM  C7105 ( 3.7A)
None
SAM  C7105 ( 2.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
HIS A6867
ASN A6841
SER A6973
ASP A6897
PHE A6901
1.62A11.07
None
SAM  A7102 ( 3.4A)
None
SAM  A7102 ( 2.6A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
HIS C6867
GLY C6879
ASN C6841
SER C6973
ASP C6897
1.46A11.07
None
SAM  C7105 ( 3.4A)
SAM  C7105 ( 3.7A)
None
SAM  C7105 ( 2.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6w75 NSP16
(SARS-CoV-2)		5 / 12
HIS C6867
GLY C6879
ASN C6841
SER C6973
ASP C6897
1.50A11.07
None
SAM  C7105 ( 3.4A)
SAM  C7105 ( 3.7A)
None
SAM  C7105 ( 2.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
HIS C6867
ASN C6841
SER C6973
ASP C6897
PHE C6901
1.62A
None
SAH  C7102 (-3.7A)
None
SAH  C7102 (-2.6A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
HIS A6867
ASN A6841
GLY A6871
ASP A6897
PHE A6901
1.79A
None
SAH  A7102 (-3.6A)
SAH  A7102 (-4.4A)
SAH  A7102 (-2.6A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
HIS C6867
GLY C6879
ASN C6841
SER C6973
ASP C6897
1.49A
None
SAH  C7102 (-3.5A)
SAH  C7102 (-3.7A)
None
SAH  C7102 (-2.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
HIS A6867
ASN A6841
SER A6973
ASP A6897
PHE A6901
1.60A
None
SAH  A7102 (-3.6A)
None
SAH  A7102 (-2.6A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
HIS A6867
GLY A6879
ASN A6841
SER A6973
ASP A6897
1.47A
None
SAH  A7102 (-3.5A)
SAH  A7102 (-3.6A)
None
SAH  A7102 (-2.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 11
GLY B 147
HIS A  59
HIS B 145
SER B  51
LEU A  56
1.44A10.63
None
ZN  B 202 (-2.6A)
ZN  B 202 (-3.3A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 11
GLY D 147
HIS C  59
HIS D 145
SER D  51
LEU C  56
1.46A10.63
None
ZN  D 202 (-3.2A)
ZN  D 202 (-3.4A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
HIS C6867
GLY C6879
ASN C6841
SER C6973
ASP C6897
1.46A
None
SFG  C7103 ( 3.5A)
FMT  C7112 ( 3.3A)
None
SFG  C7103 ( 2.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
HIS A6867
ASN A6841
SER A6973
ASP A6897
PHE A6901
1.63A
None
FMT  A7104 ( 3.1A)
None
SFG  A7103 ( 2.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
HIS C6867
ASN C6841
SER C6973
ASP C6897
PHE C6901
1.63A
None
FMT  C7112 ( 3.3A)
None
SFG  C7103 ( 2.6A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
HIS C6867
GLY C6879
ASN C6841
SER C6973
ASP C6897
1.50A
None
SFG  C7103 ( 3.5A)
FMT  C7112 ( 3.3A)
None
SFG  C7103 ( 2.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wkq NSP16
(SARS-CoV-2)		5 / 12
HIS A6867
GLY A6879
ASN A6841
SER A6973
ASP A6897
1.49A
None
SFG  A7103 ( 3.5A)
FMT  A7104 ( 3.1A)
None
SFG  A7103 ( 2.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU2_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
HIS A6917
SER A6927
GLY A6911
ASP A6912
VAL A7092
1.60A16.14
SO4  A7105 (-3.5A)
None
None
SAH  A7101 (-3.3A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
HIS A6867
ASN A6841
SER A6973
ASP A6897
PHE A6901
1.64A
None
SO4  A7109 ( 3.2A)
None
SAH  A7101 (-2.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
HIS A6867
GLY A6879
ASN A6841
SER A6973
ASP A6897
1.52A
None
SAH  A7101 (-3.5A)
SO4  A7109 ( 3.2A)
None
SAH  A7101 (-2.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		5 / 12
HIS A6917
SER A6927
GLY A6911
ASP A6912
VAL A7092
1.60A
SO4  A7105 (-3.5A)
None
None
SAH  A7101 (-3.3A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6y2g REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 11
GLY B 124
PRO A   9
SER A  10
GLY B 149
LEU B 177
1.66A17.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6yla LIGHT CHAIN
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARS-CoV-2)		5 / 12
GLY E 526
ASN E 388
SER L  62
PHE E 392
VAL E 524
1.74A
None
None
MLI  B 303 (-3.3A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6yla LIGHT CHAIN
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARS-CoV-2)		5 / 11
GLY E 329
PRO E 330
GLY C  70
LEU C  79
ILE C  81
1.75A12.86
NAG  E 906 ( 4.2A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 11
GLY B   8
SER B  21
GLY H 112
GLN H 111
LEU H   4
1.80A13.70
MLI  H 305 (-3.2A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6ym0 HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 12
ASN L 144
SER H 190
HIS H 168
PHE H 170
VAL L 169
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6yor IGG L CHAIN
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARS-CoV-2)		5 / 12
GLY E 526
ASN E 388
SER L  62
PHE E 392
VAL E 524
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6yor IGG L CHAIN
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARS-CoV-2)		5 / 12
GLY A 526
ASN A 388
SER C  62
PHE A 392
VAL A 524
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
HIS C  86
GLY C  85
ASN D 159
HIS C  91
VAL C  35
1.63A
None
None
None
EDO  C 207 ( 4.1A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
GLY C  85
HIS C  86
ASN D 159
HIS C  91
VAL C  35
1.73A
None
None
None
EDO  C 207 ( 4.1A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QU3_A_MRCA993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
GLY C  85
HIS C  86
ASN D 159
HIS C  91
VAL C  35
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FFY_A_MRCA1993_1
(ISOLEUCYL-TRNA
SYNTHETASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
HIS C  86
GLY C  85
ASN D 159
HIS C  91
VAL C  35
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JZS_A_MRCA1301_1
(ISOLEUCYL-TRNA
SYNTHETASE)		7bv2 NSP12
(SARS-CoV-2)		5 / 11
GLY A 712
HIS A 133
GLY A  44
ASP A  36
LEU A 240
1.77A21.09
None